As a pharmaceutical company, people know AstraZeneca by the medicines we make. While discovering, developing and making medicines that help improve patient health - and in many cases help save lives - will always be our main endeavor, we recognize that it cannot be our only endeavor.
People need us to do what we can to address their personal situations, which play a critical role in their healthcare decisions. They want to know we’re doing as much as we can to help people outside of the lab as we’re doing inside the lab. That’s a challenge we’ve taken on at AstraZeneca.
Because we believe healthy communities mean healthy people, we've created community-based programs that emphasize disease education and improved access to healthcare. We’re considering personal factors like finances, insurance coverage and age - to name a few - and we’re creating solutions to address them. In 2006, we extended the scope of our patient assistance programs by expanding the qualifying income levels—a change that means millions more patients may benefit.
We also recognize that compliance with clear standards and internal and external corporate governance policies are essential to maintaining our integrity and to earning your trust as well as our employees trust. These standards are exemplified by our fervent commitment to the safe, ethical, and responsible production of medicines. These standards also govern our pledge to continue to provide a healthy and safe work environment for our diverse population of employees, the very people who make new medicines a reality.
We believe in this approach to our work. That’s why we’re dedicated to continuing to challenge ourselves and others, so we can bring the best medicines and services forward for people like you. I hope you will take the time to view our Corporate Responsibility Report, and afterwards, view our new web site, www.azandme.com, which is designed to provide helpful resources and meaningful information to contribute to improving your health.
Yours Sincerely,
Tony Zook
President and CEO
AstraZeneca US
